PE64996A1 - Purin-6-ona bisustituida en 2,9 - Google Patents
Purin-6-ona bisustituida en 2,9Info
- Publication number
- PE64996A1 PE64996A1 PE1996000043A PE00004396A PE64996A1 PE 64996 A1 PE64996 A1 PE 64996A1 PE 1996000043 A PE1996000043 A PE 1996000043A PE 00004396 A PE00004396 A PE 00004396A PE 64996 A1 PE64996 A1 PE 64996A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- compound
- atoms
- carbon
- already
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE AL COMPUESTO DE FORMULA I DONDE: R1 ES ALQUILO LINEAL O RAMIFICADO CON 2 A 10 ATOMOS DE CARBONO, QUE DADO EL CASO ESTA SUSTITUIDO POR FENILO; R2 ES H, HIDROXILO, AZIDO O ALQUILO ENTRE OTROS; R3 ES H; O R2 Y R3 FORMAN JUNTOS EL RESTO DE FORMULA =O; R4 ES H O ALQUILO LINEAL O RAMIFICADO CON HASTA 4 ATOMOS DE CARBONO; A REPRESENTA UN RESTO DE 1,3 BENZODIOXOL, ALQUILO LINEAL O RAMIFICADO CON HASTA 20 ATOMOS DE CARBONO, CICLOALQUILO CON 3 A 7 ATOMOS DE CARBONO ENTRE OTROS; TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION CARACTERIZADO POR: a) TRANSFORMACION DEL COMPUESTO DE FORMULA II, EN LA CUAL R1, R2, R3 Y R4 YA SE DEFINIERON, MEDIANTE REACCION CON EL COMPUESTO DE FORMULA (III): A-CO-Cl, EN LA CUAL A YA SE DEFINIO, EN DISOLVENTES INERTES Y EN PRESENCIA DE UNA BASE, OBTENIENDOSE EL COMPUESTO DE FORMULA (IV), EN EL CUAL A, R1, R2, R3 Y R4 YA SE DEFINIERON; b) CICLACION EN DISOLVENTES INERTES Y EN PRESENCIA DE UNA BASE, INTRODUCCION DE LOS SUSTITUYENTES R1, R2, R3 Y R4 MEDIANTE ACILACION, OXIDACION Y/O INTERCAMBIO DE AZIDO. ES USADO EN EL TRATAMIENTO DE LA INFLAMACION Y ENFERMEDAD TROMBOEMBOLICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19501482A DE19501482A1 (de) | 1995-01-19 | 1995-01-19 | 2,9-disubstituierte Purin-6-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE64996A1 true PE64996A1 (es) | 1997-03-09 |
Family
ID=7751830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000043A PE64996A1 (es) | 1995-01-19 | 1996-01-19 | Purin-6-ona bisustituida en 2,9 |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5861404A (es) |
| EP (1) | EP0722944A1 (es) |
| JP (1) | JPH08231545A (es) |
| KR (1) | KR960029334A (es) |
| CN (1) | CN1135485A (es) |
| AR (1) | AR002953A1 (es) |
| AU (1) | AU4097996A (es) |
| BG (1) | BG61728B1 (es) |
| BR (1) | BR9600147A (es) |
| CA (1) | CA2167353A1 (es) |
| CO (1) | CO4700523A1 (es) |
| CZ (1) | CZ16696A3 (es) |
| DE (1) | DE19501482A1 (es) |
| EE (1) | EE9600018A (es) |
| FI (1) | FI960225A (es) |
| HR (1) | HRP960007A2 (es) |
| HU (1) | HUP9600106A3 (es) |
| IL (1) | IL116769A (es) |
| MA (1) | MA23778A1 (es) |
| NO (1) | NO960223L (es) |
| NZ (1) | NZ280830A (es) |
| PE (1) | PE64996A1 (es) |
| PL (1) | PL312354A1 (es) |
| SG (1) | SG50401A1 (es) |
| SK (1) | SK8096A3 (es) |
| SV (1) | SV1996000006A (es) |
| TN (2) | TNSN96007A1 (es) |
| TR (1) | TR199600028A2 (es) |
| TW (1) | TW314519B (es) |
| YU (1) | YU1396A (es) |
| ZA (1) | ZA96398B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529102A1 (de) * | 1995-08-08 | 1997-02-13 | Kummer Horst Dieter | Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen |
| US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| WO1999003858A1 (fr) * | 1997-07-15 | 1999-01-28 | Japan Energy Corporation | Derives purine et leur application medicinale |
| DE69824632T2 (de) * | 1997-11-12 | 2005-06-09 | Mitsubishi Chemical Corp. | Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten |
| CA2315736A1 (en) * | 1998-01-05 | 1999-07-15 | Eisai Co., Ltd. | Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus |
| US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
| US6268372B1 (en) | 1998-09-11 | 2001-07-31 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones |
| WO2000068231A1 (fr) | 1999-05-11 | 2000-11-16 | Mitsubishi Chemical Corporation | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation |
| GB9924020D0 (en) | 1999-10-11 | 1999-12-15 | Pfizer Ltd | Pharmaceutically active compounds |
| ES2381862T3 (es) * | 2000-09-06 | 2012-06-01 | Mitsubishi Tanabe Pharma Corporation | Preparaciones para administración por vía oral |
| CN100372536C (zh) * | 2001-02-15 | 2008-03-05 | 田边三菱制药株式会社 | 在口腔中迅速崩解的片剂 |
| US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| CN102742513A (zh) * | 2012-07-17 | 2012-10-24 | 南京熊猫机电制造有限公司 | 一种喂食栏装置 |
| ES2749433T3 (es) | 2014-06-23 | 2020-03-20 | Celgene Corp | Apremilast para el tratamiento de una enfermedad hepática o una anomalía de la función hepática |
| KR20210145787A (ko) | 2019-04-02 | 2021-12-02 | 알리고스 테라퓨틱스 인코포레이티드 | Prmt5를 표적으로 하는 화합물 |
| JP7385467B2 (ja) * | 2019-12-26 | 2023-11-22 | キッセイ薬品工業株式会社 | ヒポキサンチン化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
| GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
-
1995
- 1995-01-19 DE DE19501482A patent/DE19501482A1/de not_active Withdrawn
- 1995-12-27 TW TW084113907A patent/TW314519B/zh active
-
1996
- 1996-01-08 HR HR19501482.0A patent/HRP960007A2/hr not_active Application Discontinuation
- 1996-01-08 EP EP96100156A patent/EP0722944A1/de not_active Withdrawn
- 1996-01-12 YU YU1396A patent/YU1396A/sh unknown
- 1996-01-12 US US08/587,321 patent/US5861404A/en not_active Expired - Fee Related
- 1996-01-15 AU AU40979/96A patent/AU4097996A/en not_active Abandoned
- 1996-01-15 TR TR96/00028A patent/TR199600028A2/xx unknown
- 1996-01-16 CA CA002167353A patent/CA2167353A1/en not_active Abandoned
- 1996-01-16 IL IL11676996A patent/IL116769A/en not_active IP Right Cessation
- 1996-01-16 NZ NZ280830A patent/NZ280830A/en unknown
- 1996-01-17 TN TNTNSN96007A patent/TNSN96007A1/fr unknown
- 1996-01-17 TN TNTNSN96006A patent/TNSN96006A1/fr unknown
- 1996-01-17 FI FI960225A patent/FI960225A/fi unknown
- 1996-01-17 SG SG1996000260A patent/SG50401A1/en unknown
- 1996-01-17 PL PL96312354A patent/PL312354A1/xx unknown
- 1996-01-18 SK SK80-96A patent/SK8096A3/sk unknown
- 1996-01-18 ZA ZA96398A patent/ZA96398B/xx unknown
- 1996-01-18 JP JP8023473A patent/JPH08231545A/ja active Pending
- 1996-01-18 BR BR9600147A patent/BR9600147A/pt active Search and Examination
- 1996-01-18 HU HU9600106A patent/HUP9600106A3/hu unknown
- 1996-01-18 KR KR1019960001002A patent/KR960029334A/ko not_active Application Discontinuation
- 1996-01-18 MA MA24133A patent/MA23778A1/fr unknown
- 1996-01-18 EE EE9600018A patent/EE9600018A/xx unknown
- 1996-01-18 NO NO960223A patent/NO960223L/no unknown
- 1996-01-18 CZ CZ96166A patent/CZ16696A3/cs unknown
- 1996-01-18 BG BG100292A patent/BG61728B1/bg unknown
- 1996-01-19 SV SV1996000006A patent/SV1996000006A/es unknown
- 1996-01-19 CO CO96002169A patent/CO4700523A1/es unknown
- 1996-01-19 CN CN96101917A patent/CN1135485A/zh active Pending
- 1996-01-19 AR ARP960101088A patent/AR002953A1/es unknown
- 1996-01-19 PE PE1996000043A patent/PE64996A1/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE64996A1 (es) | Purin-6-ona bisustituida en 2,9 | |
| FI852974L (fi) | Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner. | |
| AR245718A1 (es) | Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina | |
| NO970495L (no) | Aryltioforbindelser som anti-bakterielle og antivirale midler | |
| ES2176698T3 (es) | Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. | |
| ES2124219T3 (es) | Agentes que proporcionan caracteristicas de deslizamiento. | |
| ATE69817T1 (de) | Tetraoxodiazabicyclo-(3,3,1)-nonane. | |
| ES2107998T3 (es) | Alcanolaminas derivatizadas como agentes cardiovasculares. | |
| DK60981A (da) | Fremgangsmaade til fremstilling af aromatiske aminoethanolforbindelser | |
| ATE86860T1 (de) | Praeparat gegen ulcus. | |
| CO4700291A1 (es) | Compuestos quimicos | |
| ITMI931012A1 (it) | Composti spiro-piranici dotati di caratteristiche fotocromatiche | |
| FI913657A0 (fi) | 4-amino-d4-steroider och deras anvaendning som 5a-reduktasinhibitorer. | |
| ES2043738T3 (es) | Procedimiento para la reduccion de cetonas. | |
| ES2011041B3 (es) | Procedimiento para la obtencion de aldehidos alifaticos y su empleo como perfumes. | |
| ES2059034T3 (es) | Procedimiento para la preparacion de carbonatos organicos. | |
| ES2038794T3 (es) | Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen. | |
| DK0470275T3 (da) | Hudhvidgørende kosmetisk præparat | |
| FI872719A0 (fi) | Nya tetrahydro-benzotiazoler, deras framstaellning och anvaendning. | |
| NO913768D0 (no) | Forbindelse, anvendelse og fremstilling. | |
| ES2129106T3 (es) | Isopropanolato de loracarbef y un procedimiento para convertir isopropanolato de loracarbef en loracarbef monohidrato. | |
| ES2045070T3 (es) | Procedimiento para la fabricacion de esteres asimetricos de dihidropiridinas. | |
| AR025418A1 (es) | Composiciones de moldeo de policarbonato, empleo de dichas composiciones para la fabricacion de cuerpos moldeados, y cuerpos moldeados obtenibles a partirde dichas composiciones | |
| ES2032461T3 (es) | Procedimiento para preparar derivados de indol. | |
| ATE154590T1 (de) | Bis-(phenolisches-amino)-chinon-derivate und damit stabilisierte polyolefinzusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |